{"id":{"repo_id":"greece","oai_identifier":"oai:10442/0413"},"canonical_url":"https://search.dev.ndltd.org/etd/greece/oai:10442/0413","repository":{"repo_id":"greece","name":"Greek National Archive of PhD Theses","base_url":"https://phdtheses.ekt.gr/eadd_oai/request"},"display":{"title":"ΜΕΛΕΤΗ ΤΩΝ ΑΝΤΙΓΟΝΩΝ ΙΣΤΟΣΥΜΒΑΤΟΤΗΤΟΣ (HLA) ΣΤΟ ΣΥΝΔΡΟΜΟ ΑΔΑΜΑΝΤΙΑΔΗ-BEHCET","abstract":"50 PATIENTS AND 512 HEALTHY CONTROL PERSONS WERE TESTED FOR THE FREQUENCY OF 35 HLA ANTIGENS (HLA-A, B, DR). THE ANTIGENS DETERMINATION WAS PERFORMED BY MEANS OF TERASAKI'S LYMPHOCYTOTOXICITY TECHNIQUE. AN INCREASED INCIDENCE OF HLA-B5 ANTIGEN WAS FOUND (74% IN THE PATIENTS, COMPARED TO 30% IN THE HEALTHY CONTROL POPULATION). THIS DIFFERENCE WAS STATISTICALLY HIGHLY SIGNIFICANT, P < 0,0001). THESE RESULTS LEADS TO THE CONCLUSION THAT POSSIBLY THERE IS A GENETIC BASIS WHICH PREDETERMINES THE SUSCEPTIBILITY OF ADAMANDIADES-BEHCET'S DISEASE AND ALSO THAT THE HLA-B5 ANTIGEN CONSTITUTES THE GENETIC MARKER OF THIS DISEASE.","abstract_html":"50 PATIENTS AND 512 HEALTHY CONTROL PERSONS WERE TESTED FOR THE FREQUENCY OF 35 HLA ANTIGENS (HLA-A, B, DR). THE ANTIGENS DETERMINATION WAS PERFORMED BY MEANS OF TERASAKI&#x27;S LYMPHOCYTOTOXICITY TECHNIQUE. AN INCREASED INCIDENCE OF HLA-B5 ANTIGEN WAS FOUND (74% IN THE PATIENTS, COMPARED TO 30% IN THE HEALTHY CONTROL POPULATION). THIS DIFFERENCE WAS STATISTICALLY HIGHLY SIGNIFICANT, P &lt; 0,0001). THESE RESULTS LEADS TO THE CONCLUSION THAT POSSIBLY THERE IS A GENETIC BASIS WHICH PREDETERMINES THE SUSCEPTIBILITY OF ADAMANDIADES-BEHCET&#x27;S DISEASE AND ALSO THAT THE HLA-B5 ANTIGEN CONSTITUTES THE GENETIC MARKER OF THIS DISEASE.","abstract_has_math":false,"creators":["Kapellou, Polyxeni","Καπέλλου, Πολυξένη"],"institution":"National and Kapodistrian University of Athens","degree_name":null,"degree_level":null,"degree_discipline":null,"degree_department":null,"school":null,"contributors":[],"advisors":[],"committee_chairs":[],"committee_members":[],"year":1985,"date_issued":"1985","date_published":"1985","updated_at":"2026-07-24T02:25:14Z","subjects":["Ανοσολογία","ADAMANDIADES-BEHCET DISEASE","HLA antigens","Ιατρική και Επιστήμες Υγείας","Κλινική Ιατρική","Medical and Health Sciences","Clinical Medicine"],"languages":["gre"],"rights":[],"rights_urls":[],"identifier_entries":[{"key":"dc:identifier","label":"Identifier","values":["10.12681/eadd/0413"],"render_values":[{"text":"10.12681/eadd/0413","href":"https://doi.org/10.12681/eadd/0413","code":true}]}]},"links":{"outbound_url":"http://hdl.handle.net/10442/hedi/0413","outbound_label":"Handle","outbound_source":"dc:identifier"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:creator","label":"Author","values":["Kapellou, Polyxeni","Καπέλλου, Πολυξένη"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["1985"]},{"key":"dc:publisher","label":"Institution","values":["National and Kapodistrian University of Athens","Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών (ΕΚΠΑ)"]},{"key":"dc:type","label":"Dc Type","values":["PhD Thesis"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Ανοσολογία","ADAMANDIADES-BEHCET DISEASE","HLA antigens","Ιατρική και Επιστήμες Υγείας","Κλινική Ιατρική","Medical and Health Sciences","Clinical Medicine"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language","label":"Dc Language","values":["gre"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["10.12681/eadd/0413","http://hdl.handle.net/10442/hedi/0413"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description","label":"Description","values":["50 PATIENTS AND 512 HEALTHY CONTROL PERSONS WERE TESTED FOR THE FREQUENCY OF 35 HLA ANTIGENS (HLA-A, B, DR). THE ANTIGENS DETERMINATION WAS PERFORMED BY MEANS OF TERASAKI'S LYMPHOCYTOTOXICITY TECHNIQUE. AN INCREASED INCIDENCE OF HLA-B5 ANTIGEN WAS FOUND (74% IN THE PATIENTS, COMPARED TO 30% IN THE HEALTHY CONTROL POPULATION). THIS DIFFERENCE WAS STATISTICALLY HIGHLY SIGNIFICANT, P < 0,0001). THESE RESULTS LEADS TO THE CONCLUSION THAT POSSIBLY THERE IS A GENETIC BASIS WHICH PREDETERMINES THE SUSCEPTIBILITY OF ADAMANDIADES-BEHCET'S DISEASE AND ALSO THAT THE HLA-B5 ANTIGEN CONSTITUTES THE GENETIC MARKER OF THIS DISEASE.","ΜΕΛΕΤΗΘΗΚΕ Η ΣΥΧΝΟΤΗΤΑ 35 HLA ΑΝΤΙΓΟΝΩΝ (HLA-A,B,DR) ΣΕ 50 ΑΤΟΜΑ ΜΕ ΣΥΝΔΡΟΜΟ ΑΔΑΜΑΝΤΙΑΔΗ-BEHCET ΚΑΙ 512 ΥΓΙΕΙΣ ΜΑΡΤΥΡΕΣ. Η ΤΥΠΟΠΟΙΗΣΗ ΤΩΝ ΑΝΤΙΓΟΝΩΝ ΕΓΙΝΕ ΜΕΤΗ ΛΕΜΦΟΚΥΤΤΑΡΟΤΟΞΙΚΗ ΔΟΚΙΜΑΣΙΑ TERASAKI. ΔΙΑΠΙΣΤΩΘΗΚΕ ΑΥΞΗΣΗ ΤΗΣ ΣΥΧΝΟΤΗΤΑΣ ΤΟΥ HLA-B5 ΑΝΤΙΓΟΝΟΥ (74% ΣΤΟΥΣ ΑΣΘΕΝΕΙΣ ΣΕ ΣΧΕΣΗ ΜΕ 30% ΣΤΗΝ ΟΜΑΔΑ ΤΩΝ ΜΑΡΤΥΡΩΝ, ΔΙΑΦΟΡΑ ΣΤΑΤΙΣΤΙΚΑ ΣΗΜΑΝΤΙΚΗ). ΤΑ ΕΥΡΗΜΑΤΑ ΜΑΣ ΟΔΗΓΟΥΝ ΣΤΟ ΣΥΜΠΕΡΑΣΜΑ ΟΤΙ ΥΠΑΡΧΕΙ ΠΙΘΑΝΩΤΑΤΑ ΓΕΝΕΤΙΚΗ ΒΑΣΗ ΚΑΙ ΚΑΘΟΡΙΖΕΙ ΤΗΝ ΕΥΣΤΑΘΕΙΑ ΣΤΗΝ ΕΚΔΗΛΩΣΗ ΤΗΣΝΟΣΟΥ ΚΑΙ ΟΤΙ ΤΟ ΑΝΤΙΓΟΝΟ HLA-B5 ΑΠΟΤΕΛΕΙ ΤΟ ΓΕΝΕΤΙΚΟ ΤΗΣ ΔΕΙΚΤΗ."]},{"key":"dc:title","label":"Title","values":["ΜΕΛΕΤΗ ΤΩΝ ΑΝΤΙΓΟΝΩΝ ΙΣΤΟΣΥΜΒΑΤΟΤΗΤΟΣ (HLA) ΣΤΟ ΣΥΝΔΡΟΜΟ ΑΔΑΜΑΝΤΙΑΔΗ-BEHCET","HLA ANTIGENS AND ADAMANDIADES-BEHCET DISEASE"]}]}],"canonical_facts":{"dc:creator":["Kapellou, Polyxeni","Καπέλλου, Πολυξένη"],"dc:date":["1985"],"dc:description":["50 PATIENTS AND 512 HEALTHY CONTROL PERSONS WERE TESTED FOR THE FREQUENCY OF 35 HLA ANTIGENS (HLA-A, B, DR). THE ANTIGENS DETERMINATION WAS PERFORMED BY MEANS OF TERASAKI'S LYMPHOCYTOTOXICITY TECHNIQUE. AN INCREASED INCIDENCE OF HLA-B5 ANTIGEN WAS FOUND (74% IN THE PATIENTS, COMPARED TO 30% IN THE HEALTHY CONTROL POPULATION). THIS DIFFERENCE WAS STATISTICALLY HIGHLY SIGNIFICANT, P < 0,0001). THESE RESULTS LEADS TO THE CONCLUSION THAT POSSIBLY THERE IS A GENETIC BASIS WHICH PREDETERMINES THE SUSCEPTIBILITY OF ADAMANDIADES-BEHCET'S DISEASE AND ALSO THAT THE HLA-B5 ANTIGEN CONSTITUTES THE GENETIC MARKER OF THIS DISEASE.","ΜΕΛΕΤΗΘΗΚΕ Η ΣΥΧΝΟΤΗΤΑ 35 HLA ΑΝΤΙΓΟΝΩΝ (HLA-A,B,DR) ΣΕ 50 ΑΤΟΜΑ ΜΕ ΣΥΝΔΡΟΜΟ ΑΔΑΜΑΝΤΙΑΔΗ-BEHCET ΚΑΙ 512 ΥΓΙΕΙΣ ΜΑΡΤΥΡΕΣ. Η ΤΥΠΟΠΟΙΗΣΗ ΤΩΝ ΑΝΤΙΓΟΝΩΝ ΕΓΙΝΕ ΜΕΤΗ ΛΕΜΦΟΚΥΤΤΑΡΟΤΟΞΙΚΗ ΔΟΚΙΜΑΣΙΑ TERASAKI. ΔΙΑΠΙΣΤΩΘΗΚΕ ΑΥΞΗΣΗ ΤΗΣ ΣΥΧΝΟΤΗΤΑΣ ΤΟΥ HLA-B5 ΑΝΤΙΓΟΝΟΥ (74% ΣΤΟΥΣ ΑΣΘΕΝΕΙΣ ΣΕ ΣΧΕΣΗ ΜΕ 30% ΣΤΗΝ ΟΜΑΔΑ ΤΩΝ ΜΑΡΤΥΡΩΝ, ΔΙΑΦΟΡΑ ΣΤΑΤΙΣΤΙΚΑ ΣΗΜΑΝΤΙΚΗ). ΤΑ ΕΥΡΗΜΑΤΑ ΜΑΣ ΟΔΗΓΟΥΝ ΣΤΟ ΣΥΜΠΕΡΑΣΜΑ ΟΤΙ ΥΠΑΡΧΕΙ ΠΙΘΑΝΩΤΑΤΑ ΓΕΝΕΤΙΚΗ ΒΑΣΗ ΚΑΙ ΚΑΘΟΡΙΖΕΙ ΤΗΝ ΕΥΣΤΑΘΕΙΑ ΣΤΗΝ ΕΚΔΗΛΩΣΗ ΤΗΣΝΟΣΟΥ ΚΑΙ ΟΤΙ ΤΟ ΑΝΤΙΓΟΝΟ HLA-B5 ΑΠΟΤΕΛΕΙ ΤΟ ΓΕΝΕΤΙΚΟ ΤΗΣ ΔΕΙΚΤΗ."],"dc:identifier":["10.12681/eadd/0413","http://hdl.handle.net/10442/hedi/0413"],"dc:language":["gre"],"dc:publisher":["National and Kapodistrian University of Athens","Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών (ΕΚΠΑ)"],"dc:subject":["Ανοσολογία","ADAMANDIADES-BEHCET DISEASE","HLA antigens","Ιατρική και Επιστήμες Υγείας","Κλινική Ιατρική","Medical and Health Sciences","Clinical Medicine"],"dc:title":["ΜΕΛΕΤΗ ΤΩΝ ΑΝΤΙΓΟΝΩΝ ΙΣΤΟΣΥΜΒΑΤΟΤΗΤΟΣ (HLA) ΣΤΟ ΣΥΝΔΡΟΜΟ ΑΔΑΜΑΝΤΙΑΔΗ-BEHCET","HLA ANTIGENS AND ADAMANDIADES-BEHCET DISEASE"],"dc:type":["PhD Thesis"]},"updated_at":"2026-07-24T02:25:14Z"}